Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-11-30 |
| Study Made Public: | 2013-05-23 |
Title
A gp41 MPER-specific llama VHH
Description
CAVD 399 is an antibody screening study which isolated and characterized a MPER-specific single chain antibody (VHH) that neutralized various sensitive and resistant HIV-1 strains, as well as SHIV strains in TZM-bl cells.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.